Published in Mediators Inflamm on January 01, 1994
Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. J Immunol (1984) 5.51
Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci U S A (1986) 3.78
Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein. Biochem J (1984) 2.47
Two high-affinity interleukin 1 receptors represent separate gene products. Proc Natl Acad Sci U S A (1989) 2.13
A cartilage catabolic factor from synovium. Biochem J (1979) 2.11
Type I IL-1 receptor blockade exacerbates murine listeriosis. J Immunol (1992) 1.78
Chondrocyte-mediated depletion of articular cartilage proteoglycans in vitro. Biochem J (1985) 1.63
Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther (1991) 1.57
Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation. Ann Rheum Dis (1990) 1.44
Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect Immun (1991) 1.42
In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice. J Immunol (1989) 1.41
Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis. J Rheumatol (1992) 1.32
Interleukin-1 (22-K factor) induces release of granulocyte-macrophage colony-stimulating activity from human mononuclear phagocytes. Blood (1986) 1.28
In vivo studies of articular tissue damage mediated by catabolin/interleukin 1. Ann Rheum Dis (1987) 1.27
Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide. J Immunol (1988) 1.21
Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice. Agents Actions (1992) 1.13
Effects of murine recombinant interleukin 1 on intact homologous articular cartilage: a quantitative and autoradiographic study. Ann Rheum Dis (1988) 1.01
Interleukin-1 induced gene expression of neutrophil activating protein (interleukin-8) and monocyte chemotactic peptide in human synovial cells. Biochem Biophys Res Commun (1991) 0.99
Arthritis induced by continuous infusion of hr-interleukin-1 alpha into the rabbit knee-joint. Int J Tissue React (1989) 0.93
Isolation and characterization of biologically active murine interleukin-1 alpha derived from expression of a synthetic gene in Escherichia coli. Biochim Biophys Acta (1989) 0.93
Regional distribution of mast cells and peptide containing nerves in normal and adjuvant arthritic rat synovium. J Rheumatol (1991) 0.91
Acute and chronic inflammatory responses to local administration of recombinant IL-1 alpha, IL-beta, TNF alpha, IL-2 and Ifn gamma in mice. Agents Actions (1989) 0.91
Arthritis induced by interleukin-1 is dependent on the site and frequency of intraarticular injection. Clin Immunol Immunopathol (1990) 0.89
The distribution and clearance of radiolabeled human interleukin-1 beta in mice. Lymphokine Res (1988) 0.89
The effects of continuous administration of murine interleukin-1 alpha in the rat. Physiol Behav (1988) 0.86
Stimulation of B cell growth and differentiation by murine recombinant interleukin 1. J Immunol (1986) 0.85
Nonsteroidal anti-inflammatory drugs: an analysis of the relationship between laboratory animal and clinical doses, including species scaling. J Pharm Sci (1988) 0.84
Reduction of exploratory behavior by intraperitoneal injection of interleukin-1 involves brain corticotropin-releasing factor. Brain Res Bull (1991) 0.83
Effects of continuously administered murine interleukin-1 alpha: tolerance development and granuloma formation. Infect Immun (1989) 0.82
Reduction of biological activity of murine recombinant interleukin-1 beta by selective deamidation at asparagine-149. FEBS Lett (1991) 0.82
Characteristics of growth-inducing exercise. Physiol Behav (1980) 0.80
The pharmacokinetics, distribution and degradation of human recombinant interleukin 1 beta in normal rats. Scand J Immunol (1991) 0.79
Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis. Proc Natl Acad Sci U S A (1995) 1.85
Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). J Clin Invest (1995) 1.35
Transgenic mice expressing the human GLUT4/muscle-fat facilitative glucose transporter protein exhibit efficient glycemic control. Proc Natl Acad Sci U S A (1993) 1.32
Collagen-induced arthritis is reduced in 5-lipoxygenase-activating protein-deficient mice. J Exp Med (1997) 1.29
Exercise protects against articular cartilage degeneration in the hamster. Arthritis Rheum (1998) 1.23
(+)-1-(3S,4R)-[3-(4-phenylbenzyl)-4-hydroxychroman-7-yl]cyclopentane carboxylic acid, a highly potent, selective leukotriene B4 antagonist with oral activity in the murine collagen-induced arthritis model. J Med Chem (1994) 1.19
Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene. J Biol Chem (1994) 1.17
Surface densities of diaphragmed fenestrae and transendothelial channels in different murine capillary beds. Circ Res (1985) 1.16
Detection of collagenase-induced damage of collagen by 9A4, a monoclonal C-terminal neoepitope antibody. Matrix Biol (1999) 1.08
Differential binding of the lectins Griffonia simplicifolia I and Lycopersicon esculentum to microvascular endothelium: organ-specific localization and partial glycoprotein characterization. Eur J Cell Biol (1990) 1.03
Purification, visualization, and biophysical characterization of Kv1.3 tetramers. J Biol Chem (1997) 1.03
The formation of fenestrations and channels by capillary endothelium in vitro. Proc Natl Acad Sci U S A (1985) 1.01
Inhibition of interleukin 1 synthesis by tenidap: a new drug for arthritis. Cytokine (1991) 1.01
Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis. J Exp Med (1996) 0.99
The pharmacologic regulation of interleukin-1 production: the role of prostaglandins. Cell Immunol (1988) 0.93
Post-capillary venules in the "milky spots" of the greater omentum are the major site of plasma protein and leukocyte extravasation in rodent models of peritonitis. Inflamm Res (1995) 0.92
The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543. J Pharmacol Exp Ther (1998) 0.87
A survey of the binding of polycationic ferritin in several fenestrated capillary beds: indication of heterogeneity in the luminal glycocalyx of fenestral diaphragms. Microvasc Res (1983) 0.87
Differential and specific labeling of epithelial and vascular endothelial cells of the rat lung by Lycopersicon esculentum and Griffonia simplicifolia I lectins. Eur J Cell Biol (1991) 0.84
Effect of levamisole on the mitosis of murine thymocytes in culture. Immunopharmacology (1979) 0.83
Effects of exercise on synovium and cartilage from normal and inflamed knees. Rheumatol Int (1995) 0.83
Murine type II collagen arthritis. Association of an acute-phase response with clinical course. Arthritis Rheum (1986) 0.83
Cartilage damage after intraarticular exposure to collagenase 3. Osteoarthritis Cartilage (2000) 0.82
Fetal and neonatal rat intestinal capillaries: a TEM study of changes in the mural structure. Am J Anat (1981) 0.81
Extracellular matrix specificity for the differentiation of capillary endothelial cells. Exp Cell Res (1988) 0.80
Histology and tissue chemistry of tidemark separation in hamsters. Vet Pathol (1999) 0.80
The endothelial pocket. A new structure in fenestrated endothelia. Cell Tissue Res (1986) 0.80
Bafilomycin A1 inhibits IL-1-stimulated proteoglycan degradation by chondrocytes without affecting stromelysin synthesis. Arch Biochem Biophys (1995) 0.79
Carrageenan pleurisy. Methods Enzymol (1988) 0.79
Effects of levamisole on the proliferation of thymic lymphocyte subpopulations. Immunopharmacology (1981) 0.78
Anti-arthritic effect of bee venom. Agents Actions (1979) 0.78
The mechanism of tumor allograft survival induced by CP-17,193. Immunopharmacology (1982) 0.77
Fetal and neonatal rat intestinal capillaries: permeability to carbon, ferritin, hemoglobin, and myoglobin. Am J Anat (1982) 0.77
Comparison of mobility changes with histological and biochemical changes during lipopolysaccharide-induced arthritis in the hamster. Am J Pathol (1994) 0.77
The effect of interleukin-1 on adhesion formation in the rat. Am J Obstet Gynecol (1991) 0.76
Possible role of IL-1 in arthritis: effects of prostaglandins in the regulation of IL-1 synthesis and actions. Agents Actions Suppl (1993) 0.75
Determining selectivity of drugs by quantitative two-dimensional gel analysis. A study of tenidap, piroxicam, and dexamethasone. Biochem Pharmacol (1996) 0.75
Isoxazolyl, oxazolyl, and thiazolylpropionic acid derivatives as potent alpha(4)beta(1) integrin antagonists. Bioorg Med Chem Lett (2001) 0.75
Cyclophosphamide and 15(S)-15 methyl PGE1 correct the T/B lymphocyte ratios of NZB/NZW mice. Agents Actions (1990) 0.75
Interaction of levamisole and mercaptans during thymocyte proliferation induced by concanavalin A. Cell Immunol (1979) 0.75
Some factors affecting inhibition and restoration of mobility after induction of an acute arthritis in the hamster. Agents Actions (1993) 0.75
Effects of dazmegrel, piroxicam and cyclophosphamide on the NZB/W model of SLE. Agents Actions (1989) 0.75